Expression of CD95 and CD95L on astrocytes in the CA1 area of the immature rat hippocampus after hypoxia-ischemia injury

Comparative Medicine

Volumn 57, Issue 6, 2007, Pages 581-589

  Myeung, Ju Kim ^a   Lim, Hyoung Soo ^b,c   Young, Bok Yoo ^a   Young, Il Lee ^a   Hahm, Dae Hyun ^b   Lee, Hye Jung ^b   Kee, Wook Jung ^d   Kim, Jong Wan ^e   Sung, Moon Yoe ^e   Chung, David Chanwook ^a   Young, Pyo Chang ^a  

^a Dankook University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Korean National Police Agency   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Dankook University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; FAS ANTIGEN; FAS LIGAND;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ASTROCYTES; FAS LIGAND PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; HYPOXIA-ISCHEMIA, BRAIN; IN SITU NICK-END LABELING; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 38049017945     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Becher B, D'Souza SD, Troutt AB, Antel JP. 1998. Fas expression on human fetal astrocytes without susceptibility to Fas-mediated cytotoxicity. Neuroscience 84:627-634.
2. Bechmann I, Lossau S, Steiner B, Mor G, Gimsa U, Nitsch R. 2000. Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration. Glia 32:25-41.
3. Bechmann, I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F. 1999. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27:62-74.
4. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, Mallard C, Hagberg H. 2001. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 276:10191-10198.
5. Bonetti B, Pohl J, Gao YL, Raine CS. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 159:5733-5741.
6. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC. 1999. Fas/Apo[apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspasedependent cell death and activation of NF-κB. J Neurosci 19:1754-1770.
7. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, Choi IH. 1999. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL1, IL6, TNFα, or IFNγ. J Immunol 162:1889-1895.
8. Ciccarelli R, D'Alimonte I, Ballerini P, D'Auro M, Nargi E, Buccella S, Di Iorio P, Bruno V, Nicoletti F, Caciagli F. 2007. Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes. Mol Pharmacol 71:1369-1380.
9. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184:2361-2370.
10. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. 1996. Involvement of the CD95 (APO1/Fas) receptor-ligand system in multiple sclerosis brain. J Exp Med 184:1513-1518.
11. Felderhoff-Mueser U, Taylor DL, Greenwood K, Kozma M, Stibenz D, Joashi UC, Edwards AD, Mehmet H. 2000. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxicischemic injury to the developing rat brain. Brain Pathol 10:17-29.
12. Jin K, Graham SH, Mao X, Nagayama T, Simon RP, Greenberg DA. 2001. Fas (CD95) may mediate delayed cell death in hippocampal CA1 sector after global cerebral ischemia. J Cereb Blood Flow Metab 21:1411-1421.
13. Kawahara N, Wang Y, Mukasa A, Furuya K, Shimizu T, Hamakubo T, Aburatani H, Kodama T, Kirino T. 2004. Genome-wide gene expression analysis for induced ischemic tolerance and delayed neuronal death following transient global ischemia in rats. J Cereb Blood Flow Metab 24:212-223.
14. Kim MJ, Shin KS, Chung YB, Jung KW, Cha CI, Shin DH. 2005. Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain. Brain Res 1040:178-186.
15. Lee SJ, Zhou T, Choi C, Wang Z, Benveniste EN. 2000. Differential regulation and function of Fas expression on glial cells. J Immunol 164:1277-1285.
16. Leist M, Jaattela M. 2001. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-598.
17. Malipiero U, Frei K, Spanaus KS, Agresti C, Lassmann H, Hahne M, Tschopp J, Eugster HP, Fontana A. 1997. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perform knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur J Immunol 27:3151-3160.
18. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. 1994. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301-311.
19. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753-3758.
20. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365.
21. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press.
22. Ota K, Yakovlev AG, Itaya A, Kameoka M, Tanaka Y, Yoshihara K. 2002. Alteration of apoptotic protease-activating factor-1 (APAF-1)-dependent apoptotic pathway during development of rat brain and liver. J Biochem (Tokyo) 131:131-135.
23. Padosch SA, Popp E, Vogel P, Bottiger BW. 2003. Altered protein expression levels of Fas/CD95 and Fas ligand in differentially vulnerable brain areas in rats after global cerebral ischemia. Neurosci Lett 338:247-251.
24. Palma JP, Yauch RL, Lang S, Kim BS. 1999. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination. J Immunol 162:6543-6551.
25. Puka-Sundvall M, Wallin C, Gilland E, Hallin U, Wang X, Sandberg M, Karlsson J, Blomgren K, Hagberg H. 2000. Impairment of mitochondrial respiration after cerebral hypoxiaischemia in immature rats: relationship to activation of caspase-3 and neuronal injury. Brain Res Dev Brain Res 125:43-50.
26. Saas P, Boucraut J, Quiquerez AL, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker PR, Dietrich PY. 1999. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J Immunol 162:2326-2333.
27. Shin DH, Lee E, Kim JW, Kwon BS, Jung MK, Jee YH, Kim J, Bae SR, Chang YP. 2004. Protective effect of growth hormone on neuronal apoptosis after hypoxia-ischemia in the neonatal rat brain. Neurosci Lett 354:64-68.
28. Spanaus KS, Schlapbach R, Fontana A. 1998. TNFα and IFNγ render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and downregulation of Bcl-2 and Bcl-xL. Eur J Immunol 28:4398-4408.
29. Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, Guiba-Tziampiri O. 2005. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 1045:22-30.
30. Travis J. 1994. Glia: the brain's other cells. Science 266:970-972.
31. Vannucci RC. 2000. Hypoxic-ischemic encephalopathy. Am J Perinatal 17:113-120.
32. Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J. 1997. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 124:1239-1249.
33. White CA, McCombe PA, Pender MP. 1999. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95). Int Immunol 10:935-941.
34. Wiessner C, Sauer D, Alaimo D, Allegrini PR. 2000. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo. Cell Mol Biol 46:53-62.
35. Zhu C, Qiu L, Wang X, Hallin U, Cande C, Kroemer G, Hagberg H, Blomgren K. 2003. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 86:306-317.
36. Zhu C, Wang X, Xu F, Bahr BA, Shibata M, Uchiyama Y, Hagberg H, Blomgren K. 2005. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 12:162-176.
37. Zuliani C, Kleber S, Klussmann S, Wenger T, Kenzelmann M, Schreglmann N, Martinez A, del Rio JA, Soriano E, Vodrazka P, Kuner R, Groene HJ, Herr I, Krammer PH, Martin-Villalba A. 2006. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 13:31-40.